 Notwithstanding this knowledge, the company allegedly proceeded to market the product for VCFs without putting it through FDA-required testing.The company, it is alleged, did not stop marketing the product until after a third patient had died on the operating table.In late 2011, all four executives received prison sentences ranging from five to nine months.